Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01819168

Enrollment

Registered

2013-03-27

Start date

2013-03-31

Completion date

2016-04-30

Last updated

2016-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder Syndrome

Brief summary

The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 99 Years

Healthy volunteers

Inclusion criteria

* patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics & Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
bladder diary	3 months	To clarity any difference of reduction in the episodes of nocturia between these two groups.

Secondary

Measure	Time frame	Description
Frequency and Urgency	3 months	To clarity any difference of reduction in the episodes of urinary frequency and urgency between these two groups.

Countries

Taiwan

Outcome results